307280 — Wonbiogen Co Share Price
Last trade - 00:00- KR₩49bn
- KR₩44bn
- KR₩30bn
- 77
- 61
- 37
- 65
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | n/a | ||
| PEG Ratio (f) | n/a | ||
| EPS Growth (f) | n/a | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 1.45 | ||
| Price to Tang. Book | 1.49 | ||
| Price to Free Cashflow | 11.18 | ||
| Price to Sales | 1.68 | ||
| EV to EBITDA | 5.33 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 18.67% | ||
| Return on Equity | 14.17% | ||
| Operating Margin | 22.49% | ||
Financial Summary
| Year End 31st Dec | Unit | 2019 | 2020 | 2021 | 2022 | 2023 | 2024E | 2025E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | KR₩m | n/a | n/a | 17,720.82 | 26,747.72 | 29,614.74 | 43,200 | n/a | n/a |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +52.52 | +94.87 | n/a | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Wonbiogen Co Ltd, formerly Kyobo 8 Special Purpose Acquisition Co, is a Korea-based company engaged in the manufacturing and sale of medical supplies. The Company provides medical products including dressing material used for lower leg ulcers, pressure ulcers and surgical wounds; dressing material for secretions absorption and wound area protection; fixing band for bandages, gauze, catheters, along with others.
Directors
- Last Annual
- December 31st, 2023
- Last Interim
- June 30th, 2024
- Incorporated
- September 3rd, 2018
- Public Since
- December 5th, 2018
- No. of Shareholders
- 7,447
- No. of Employees
- 54
- Sector
- Healthcare Equipment & Supplies
- Industry
- Healthcare
- Exchange
- Korea Exchange - KOSDAQ
- Shares in Issue
- 35,472,878
- Address
- 56, 1Gongdan-Ro 5-Gil, GUMI, 39372
- Web
- http://www.wonbiogen.co.kr/
- Phone
- +82 544627965
- Auditors
- Jeong Jin-rim accounting firm
Upcoming Events for 307280
Similar to 307280
Access Bio
Korea Exchange - KOSDAQ
Aligned Genetics
Korea Exchange - KOSDAQ
Alphanox Co
Korea Exchange - KOSDAQ
Angel Robotics Co
Korea Exchange - KOSDAQ
Asta Co
Korea Exchange - KOSDAQ
FAQ
As of Today at 24:08 UTC, shares in Wonbiogen Co are trading at KR₩1,394. This share price information is delayed by 15 minutes.
Shares in Wonbiogen Co last closed at KR₩1,394 and the price had moved by -17.36% over the past 365 days. In terms of relative price strength the Wonbiogen Co share price has underperformed the FTSE Developed Asia Pacific Index by -30.08% over the past year.
The overall consensus recommendation for Wonbiogen Co is Strong Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreThe Wonbiogen Co dividend yield is 1.43% based on the trailing twelve month period.
Last year, Wonbiogen Co paid a total dividend of KR₩20, and it currently has a trailing dividend yield of 1.43%. We do not have any data on when Wonbiogen Co is to next pay dividends.
We do not have data on when Wonbiogen Co is to next pay dividends. The historic dividend yield on Wonbiogen Co shares is currently 1.43%.
To buy shares in Wonbiogen Co you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of KR₩1,394, shares in Wonbiogen Co had a market capitalisation of KR₩49bn.
Here are the trading details for Wonbiogen Co:
- Country of listing: Korea, Republic of
- Exchange: KOE
- Ticker Symbol: 307280
Based on an overall assessment of its quality, value and momentum Wonbiogen Co is currently classified as a Contrarian. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
We could not find analyst target price data for this security.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Wonbiogen Co. Over the past six months, its share price has underperformed the FTSE Developed Asia Pacific Index by -28.33%.
As of the last closing price of KR₩1,394, shares in Wonbiogen Co were trading -14.56% below their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Wonbiogen Co PE ratio based on its reported earnings over the past 12 months is null. The shares last closed at KR₩1,394.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
We do not have data on Wonbiogen Co's directors